Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$39.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 44 most recent Form 4 transactions.
| Boston Scientific Corp |
| GGIFT |
| 386,755 |
| — |
| — |
| -100.0% |
| Open the original filing on SEC.gov |
| May 14 | CVS | CVS HEALTH Corp | AGRANT◆ | 1,737 | $97.15 | $168.8K | — | Open the original filing on SEC.gov |
| Feb 16 | BSX | Boston Scientific Corp | MEXER◆ | 16,265 | — | — | — | Open the original filing on SEC.gov |
| Feb 16 | BSX | Boston Scientific Corp | FTAX | 7,865 | $74.73 | $587.8K | -0.5% | Open the original filing on SEC.gov |
| Feb 16 | BSX | Boston Scientific Corp | MEXER | 16,265 | — | — | +1.0% | Open the original filing on SEC.gov |
| Feb 14 | BSX | Boston Scientific Corp | MEXER◆ | 16,524 | — | — | — | Open the original filing on SEC.gov |
| Feb 14 | BSX | Boston Scientific Corp | FTAX | 7,990 | $74.73 | $597.1K | -0.5% | Open the original filing on SEC.gov |
| Feb 14 | BSX | Boston Scientific Corp | MEXER | 16,524 | — | — | +1.1% | Open the original filing on SEC.gov |
| Feb 13 | BSX | Boston Scientific Corp | MEXER◆ | 8,832 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | BSX | Boston Scientific Corp | FTAX | 132,099 | $74.73 | $9.9M | -7.8% | Open the original filing on SEC.gov |
| Feb 13 | BSX | Boston Scientific Corp | MEXER | 8,832 | — | — | +0.5% | Open the original filing on SEC.gov |
| Feb 13 | BSX | Boston Scientific Corp | AGRANT | 132,190 | — | — | +8.5% | Open the original filing on SEC.gov |
| Feb 13 | BSX | Boston Scientific Corp | AGRANT | 132,190 | — | — | +9.3% | Open the original filing on SEC.gov |
| Feb 12 | BSX | Boston Scientific Corp | AGRANT◆ | 131,329 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | BSX | Boston Scientific Corp | AGRANT◆ | 55,652 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | BSX | Boston Scientific Corp | MEXER◆ | 13,704 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | BSX | Boston Scientific Corp | FTAX | 6,626 | $74.12 | $491.1K | -0.5% | Open the original filing on SEC.gov |
| Feb 12 | BSX | Boston Scientific Corp | MEXER | 13,704 | — | — | +1.0% | Open the original filing on SEC.gov |
| Feb 2 | BSX | Boston Scientific Corp | MEXER◷◆ | 49,407 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | BSX | Boston Scientific Corp | MEXER◷◆ | 46,347 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | BSX | Boston Scientific Corp | SSELL◷ | 159,701 | $93.49 | $14.9M | -10.2% | Open the original filing on SEC.gov |
| Feb 2 | BSX | Boston Scientific Corp | SSELL◷ | 1,200 | $94.06 | $112.9K | <0.1% | Open the original filing on SEC.gov |
| Feb 2 | BSX | Boston Scientific Corp | MEXER◷ | 46,347 | $27.09 | $1.3M | +3.0% | Open the original filing on SEC.gov |
| Feb 2 | BSX | Boston Scientific Corp | MEXER◷ | 49,407 | $24.55 | $1.2M | +3.4% | Open the original filing on SEC.gov |
| Nov 20, 2025 | CVS | CVS HEALTH Corp | AGRANT◆ | 2,021.96 | $76.04 | $153.8K | — | Open the original filing on SEC.gov |
| Oct 30, 2025 | BSX | Boston Scientific Corp | GGIFT | 149,992 | — | — | -41.2% | Open the original filing on SEC.gov |
| Oct 29, 2025 | BSX | Boston Scientific Corp | GGIFT | 73,996 | — | — | +25.5% | Open the original filing on SEC.gov |
| Oct 29, 2025 | BSX | Boston Scientific Corp | GGIFT | 88,197 | — | — | +43.8% | Open the original filing on SEC.gov |
| Jun 2, 2025 | BSX | Boston Scientific Corp | MEXER◷◆ | 49,407 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | BSX | Boston Scientific Corp | MEXER◷◆ | 56,212 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | BSX | Boston Scientific Corp | SSELL◷ | 89,921 | $103.39 | $9.3M | -5.7% | Open the original filing on SEC.gov |
| Jun 2, 2025 | BSX | Boston Scientific Corp | SSELL◷ | 74,522 | $104.05 | $7.8M | -4.5% | Open the original filing on SEC.gov |
| Jun 2, 2025 | BSX | Boston Scientific Corp | MEXER◷ | 49,407 | $24.55 | $1.2M | +3.1% | Open the original filing on SEC.gov |
| Jun 2, 2025 | BSX | Boston Scientific Corp | MEXER◷ | 56,212 | $17.26 | $970.2K | +3.7% | Open the original filing on SEC.gov |
| May 15, 2025 | CVS | CVS HEALTH Corp | AGRANT◆ | 2,542.58 | $60.47 | $153.8K | — | Open the original filing on SEC.gov |
| May 15, 2025 | CVS | CVS HEALTH Corp | AGRANT | 144 | $60.47 | $8.7K | +2.3% | Open the original filing on SEC.gov |
| May 1, 2025 | BSX | Boston Scientific Corp | MEXER◷◆ | 49,407 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | BSX | Boston Scientific Corp | MEXER◷◆ | 56,212 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | BSX | Boston Scientific Corp | SSELL◷ | 91,282 | $102.13 | $9.3M | -5.6% | Open the original filing on SEC.gov |
| May 1, 2025 | BSX | Boston Scientific Corp | SSELL◷ | 73,161 | $102.92 | $7.5M | -4.3% | Open the original filing on SEC.gov |
| May 1, 2025 | BSX | Boston Scientific Corp | MEXER◷ | 49,407 | $24.55 | $1.2M | +3.0% | Open the original filing on SEC.gov |
| May 1, 2025 | BSX | Boston Scientific Corp | MEXER◷ | 56,212 | $17.26 | $970.2K | +3.5% | Open the original filing on SEC.gov |